Jane Gross

Jane Gross

Director/Board Member at ATYR PHARMA, INC.

Net worth: 5 538 $ as of 30/05/2026

69 year
Health Technology
Consumer Services
Commercial Services

Profile

Jane A. Gross currently works at aTyr Pharma, Inc., as Independent Director from 2019, Life Science Washington, as Director, BriaCell Therapeutics Corp., as Independent Director from 2022, and BriaPro Therapeutics Corp., as Independent Director.
Dr. Gross also formerly worked at ZymoGenetics, Inc., as Vice President-Immunology Research from 2009 to 2010, Emergent BioSolutions, Inc., as VP-Applied Research & Non-Clinical Development from 2011 to 2016, and Aptevo Therapeutics, Inc., as Chief Scientific Officer & Senior Vice President from 2016 to 2021.
Dr. Gross received her doctorate degree in 1990 from the University of California, Berkeley.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
10/05/2026 9,750 ( 0.01% ) 5 294 $ 30/05/2026
27/01/2026 66 ( 0% ) 240 $ 30/05/2026
0.5%
31/03/2026 359,000 ( 0.5% ) 4 $ 30/03/2026

Jane Gross active positions

CompaniesPositionStart
ATYR PHARMA, INC. Director/Board Member 27/06/2019
BRIACELL THERAPEUTICS CORP. Director/Board Member 17/01/2022
Director/Board Member -
Director/Board Member -

Former positions of Jane Gross

CompaniesPositionEnd
APTEVO THERAPEUTICS INC. Chief Tech/Sci/R&D Officer 13/09/2021
EMERGENT BIOSOLUTIONS INC. Corporate Officer/Principal 31/07/2016
Corporate Officer/Principal 31/05/2010
See the detail of Jane Gross's experience

Training of Jane Gross

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

78

1st degree connections

8

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies8

Health Technology

Health Technology

Consumer Services

Health Technology

Commercial Services

Health Technology

Health Technology

Health Technology

- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!